Gessel has advised Pure Biologics and its shareholder Filip Jelen on an investment from Michal Lach. DZP advised Michal Lach.

Turunc has advised Pollet Medical Group on obtaining the approval of the Turkish Competition Board for the majority acquisition of Farmasol.

E+H, working with McDermott Will & Emery, has advised Ligand Pharmaceuticals Incorporated on its acquisition of Apeiron Biologics. Baker McKenzie advised Apeiron's shareholders. Dorda reportedly advised Apeiron.

DZP, working with Orrick, has advised Rubicon Partners on its USD 2.5 million investment in StaffHealth.

Kinstellar has advised Edwards Lifesciences on data protection legal matters via a secondment arrangement.

Ellex has advised Specialist VC as the lead investor on the EUR 1.75 million seed round for Estonian medtech company Nanordica Medical.